Tag Archives: U.S.

Exelixis Announces U.S. FDA Approval of Cabometyx (cabozantinib) Tablets for Previously Treated Hepatocellular Carcinoma

Print this page ALAMEDA, Calif.–(BUSINESS WIRE)–Jan. 14, 2019– Exelixis, Inc. (NASDAQ:EXEL) today announced that the U.S. Food and Drug Administration (FDA) approved Cabometyx (cabozantinib) tablets for patients with hepatocellular carcinoma (HCC) who have been previously treated with sorafenib. HCC is the most common form of liver cancer and the fastest-rising cause of cancer-related death in… Read More »

Second U.S. judge blocks Trump administration birth control rules

(Reuters) – A federal judge in Pennsylvania on Monday blocked the Trump administration from enforcing new rules allowing employers to obtain exemptions from an Obamacare requirement that they provide health insurance that covers women’s birth control. FILE PHOTO: An illustration picture shows a woman holding a birth control pill at her home in Nice January… Read More »